Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
Blog 6 August 2024 Medications for respiratory tract infections: The good, the unreliable, and the old fashioned Your respiratory tract is made up of an upper section (mouth, throat, nose, sinuses and vocal cords) and a lower... Continue Reading
News 2 August 2024 Wegovy to be available in Australia A new weight loss medicine, Wegovy, will be available in Australia from early August 2024. Pharmaceutical company Novo Nordisk made... Continue Reading
Blog 12 July 2024 Melanie & Andrew’s story Melanie didn’t anticipate her son Andrew’s type 1 diabetes diagnosis at 7 years of age. “We didn’t have the right level of coverage for an insulin pump." Continue Reading
